The external environment is leading a savage assault on skin: Oxidative Ageingi is the cumulative, damaging effect of particulate matter, infrared radiation, High Energy Visible Light (HEV, or blue light), pollution, ozone, and UVA/UVB rays, which are outpacing our skin’s biological ability to adapt.
In fact, this perfect storm of factors is responsible for between 80% and 90% of extrinsic skin ageingii with chronic exposure generating free radical damage, triggering a vicious cycle of oxidative stress and inflammation - breaking down collagen, elastin, and barrier lipids, while accelerating visible signs of ageing.
However, an ingredient derived from the sustainable Alteromonas bacteria found in the unique marine ecosystem in French Polynesia, could be the key to protecting skin. Exo-P™, exclusive to AlumierMD formulations, forms a breathable, biomimetic shield when applied to the skin, mimicking its natural barrier and trapping pollution particles as small as PM2.5.”
A recent ex vivo human skin explant studyiii of Exo-P™ mimicked a real-life scenario in which skin might be exposed to particulate matter and later cleansed. One skin sample was treated with an AlumierMD formulation containing Exo-P; the other was untreated as a control.
Videoscope images of the treated skin samples at 15x and 50x magnification proved Exo-P™ effectively traps charcoal particulates on the skin’s surface, to be easily washed away. The treated skin also showed a significant reduction in the number of particulates at both magnification levels. Additionally, quantitative analysis of the residual particulates collected in the wash confirmed that a higher number of particulate matter was collected from the skin treated with the Exo-P™ formulation.
FURTHER INFORMATION
Alumier MD
www.alumiermd.co.uk
-------------------------------------------------------------------------------
i AlumierMD is in the process of trademarking the terms ‘Oxidative Ageing’ and ‘Oxidative Aging’
ii Journal of Dermatological Science: American Academy of Dermatology
iii An ex vivo laboratory study on human skin explants conducted by an independent laboratory in the USA, January 2024
